 |
|
|
| |
Real-World Effectiveness of Glecaprevir/Pibrentasvir
in 1,941 Patients with Hepatitis C Genotypes 1 through 4
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 San Francisco
Dr. Pamela S. Belperio, Dr. Troy Shahoumian, Dr. Timothy Loomis, Dr. Larry Mole and Dr. Lisa I. Backus, Population Health, VA Palo Alto Healthcare System
|
| |
|
|
|
|
|
